Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0615
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-08-01T06:07:52.737521Z
status: published
lens: g_space
sector: health
headline: Multiomics Profiling Identifies Blood-Based Diagnostic Markers for Sepsis
dek: Sepsis, characterized by a rapid transition to systemic immune dysregulation and multiorgan failure, poses a formidable clinical challenge. The lack of spatiotemporally stable biomarkers severely impedes early diagnosis and risk stratification. By integrating large-scale transcriptomic profiling with machine learning algorithms, this study identified a robust three-gene diagnostic signature (TLR5, HMGB2, and C19orf59). Single-cell RNA sequencing precisely localized the sepsis-induced specific upregulation of the…
gain_title: Integrating large-scale transcriptomic profiling with machine learning identified a three-gene blood signature that enables early sepsis diagnosis and risk stratification across severity levels.
problem_title: (none)
trace_subject: (none)
gain_reading: Integrating large-scale transcriptomic profiling with machine learning identified a three-gene blood signature that enables early sepsis diagnosis and risk stratification across severity levels.
gain_evidence: identified a robust three-gene diagnostic signature (TLR5, HMGB2, and C19orf59) | establishes TLR5, HMGB2, and C19orf59 as a highly reliable diagnostic and severity-stratification panel
problem_reading: (none)
problem_evidence: (none)
quick_read: By August 1, 2026, researchers reported integrating large-scale transcriptomic profiling with machine learning to identify TLR5, HMGB2, and C19orf59 as a blood-based diagnostic signature for sepsis. They mapped expression to myeloid cells and tested the panel across SOFA-defined severity strata, then validated it in sham-controlled CLP mice, LPS-stimulated cells, and sepsis patient serum.

The work matters because sepsis lacks spatiotemporally stable biomarkers for early diagnosis, and a reliable blood panel could improve triage and risk stratification. What remains uncertain from this text is prospective clinical performance, generalizability beyond the studied cohorts, and how the signature would integrate into existing diagnostic workflows.
limitation: 
tag: Evidence-backed gain
key_points: Machine learning on transcriptomic data identified TLR5, HMGB2, and C19orf59 as a diagnostic signature for sepsis. | Single-cell RNA sequencing localized upregulation to monocytes and neutrophils in the myeloid compartment. | Validation included sham-controlled CLP murine models, LPS-stimulated cell models, and independent sepsis patient serum.
rundown: The study combined large-scale transcriptomic profiling with machine learning to derive the three-gene panel, then used single-cell RNA sequencing to localize expression to monocytes and neutrophils. Severity analysis based on SOFA scores showed TLR5 and HMGB2 excel in high-risk cases while C19orf59 maintains efficacy across all strata.

Validation was multidimensional: strictly time-matched sham-controlled cecal ligation and puncture murine models showed persistent upregulation across lung, heart, liver and systemic circulation, and vehicle-controlled in vitro LPS models revealed HMGB2 exhibiting a distinct biphasic kinetic profile characteristic of DAMPs, followed by clinical validation in patient serum.
sources:
- peer_reviewed | Journal of Cellular Physiology | https://doi.org/10.1002/jcp.70213 | 2026-08-01
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

c6cf4b1142c533e843530ba49fb5bbdc1235331ca11b35a4372866f9776bbc34

previous

0000000000000000000000000000000000000000000000000000000000000000